REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 433 filers reported holding REPLIGEN CORP in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $480,240 | +10.7% | 3,018 | -1.5% | 0.00% | 0.0% |
| Q2 2023 | $433,923 | -14.5% | 3,064 | +1.7% | 0.00% | 0.0% |
| Q1 2023 | $507,629 | -67.5% | 3,012 | -81.7% | 0.00% | -33.3% |
| Q4 2022 | $1,560,201 | +46.2% | 16,446 | +188.6% | 0.00% | -40.0% |
| Q3 2022 | $1,067,000 | +15.6% | 5,699 | +0.2% | 0.01% | +25.0% |
| Q2 2022 | $923,000 | -14.3% | 5,686 | -0.8% | 0.00% | -20.0% |
| Q1 2022 | $1,077,000 | -29.4% | 5,730 | -0.6% | 0.01% | -16.7% |
| Q4 2021 | $1,526,000 | -8.2% | 5,763 | +0.2% | 0.01% | -14.3% |
| Q3 2021 | $1,662,000 | +45.2% | 5,753 | +0.4% | 0.01% | +40.0% |
| Q2 2021 | $1,145,000 | +1.1% | 5,732 | -1.5% | 0.01% | 0.0% |
| Q1 2021 | $1,132,000 | -8.9% | 5,822 | -10.2% | 0.01% | 0.0% |
| Q4 2020 | $1,242,000 | +27.3% | 6,481 | -2.0% | 0.01% | 0.0% |
| Q3 2020 | $976,000 | +306.7% | 6,612 | +240.5% | 0.01% | +400.0% |
| Q2 2020 | $240,000 | +7.6% | 1,942 | -25.0% | 0.00% | 0.0% |
| Q2 2019 | $223,000 | – | 2,591 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |